SCM
CLB icon

Southport Capital Management’s Core Laboratories CLB Stock Holding History

Southport Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$974K Buy
+30,794
New +$863K 0.36% 75

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
CPH
C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return

Southport Capital Management's CLB Position: Q1 2022 in Review

Southport Capital Management opened a new position in Core Laboratories (CLB) in Q1 2022: 30,794 shares worth $974K. The stake represents 0.36% of the portfolio and ranks #75 among its holdings.

196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.

  • Southport Capital Management held 30,794 shares of Core Laboratories worth $974K as of Q1 2022.
  • Core Laboratories was a new Southport Capital Management position in Q1 2022.
  • Core Laboratories made up 0.36% of Southport Capital Management's portfolio in Q1 2022, its #75 holding.
  • 196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.

Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.